Which is more profitable, Amgen or Merck &?

Merck & keeps more of every sale as profit.

Which grows faster, Amgen or Merck &?

Merck & grew its sales faster in recent years.

Which is cheaper, Amgen or Merck &?

Merck & costs less for each unit of yearly profit (lower P/E).

Which has less debt, Amgen or Merck &?

Merck & would need fewer years of earnings to pay off its debt.

AmgenAMGNvs

Merck &MRK

Amgen vs Merck & stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Merck & is more profitable, grows faster, is cheaper for its profits and has less debt.

Side by side

	Amgen	Merck &
	$252 billion	$364 billion
	21.0%	28.1%
	+7.6%	+9.4%
	32.7×	20.0×
	2.7 years	1.2 years
	15.0%	17.8%
	2.9%	2.8%

Open Amgen Open Merck &

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Amgen vs Regeneron Pharmaceuticals · Amgen vs Roche · Amgen vs Revolution Medicines · Amgen vs Thermo Fisher Scientific · Merck & vs argenx · Merck & vs Bayer · Merck & vs Gilead Sciences · Merck & vs Intuitive Surgical